Using Artificial Intelligence to Predict Rectal Cancer Outcomes
NCT ID: NCT05723965
Last Updated: 2023-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
720 participants
OBSERVATIONAL
2010-10-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Using artificial intelligence CNN on jupyter notebook with open phyton code to train and develop models capable to recognizing local advanced rectal cancer. Modify the phyton code for better predict rate and help physician to quickly evaluate disease severity for fresh rectal cancer cases.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
3D Modeling for Detecting Locally Advanced Rectal Cancer With Positive Circumferential Resection Margin
NCT07183124
Deep Learning Based MRI Radiomics in Predicting the Clinical Risk of Locally Advanced Rectal Cancer
NCT06314750
Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer
NCT04273477
RadioPathomics Artificial Intelligence Model to Predict nCRT Response in Locally Advanced Rectal Cancer
NCT04271657
Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI
NCT05523245
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
rectal cancer lesion images for training
Rectal cancer lesion images. Images with threatened (\<2mm) circumferential margin of rectal cancer were labeled as "diseased". Otherwise, images were labeled as "normal". Using these materials as training materials for AI deep learning model buildup.
As training material for deep learning model.
Using labeled images as training materials for artificial intelligence to develop object detecting model.
rectal cancer lesion images for testing.
Using the buildup AI deep learning models from training cohort. Evaluating prediction rate of the model and analysis survival outcomes.
As materials for external validation for the buildup model.
Using the external validation set to evaluate prediction rate and survival outcome.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
As training material for deep learning model.
Using labeled images as training materials for artificial intelligence to develop object detecting model.
As materials for external validation for the buildup model.
Using the external validation set to evaluate prediction rate and survival outcome.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* 2\. not localizing rectum
* 3\. T1-2 lesion
* 4\. non contrast or poor quality images
20 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taichung Veterans General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ChunuYu Lin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Taichung Veterans General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taichung Verterans General Hospital
Taichung, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CE21235B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.